GSK1265744 rapidly suppresses HIV and appears safe at selected dose
HIV-positive people not on antiretrovirals are prone to inflammation-related bone loss
Eviplera works well regardless of viral load or CD4 count, may improve lipid levels
Does efavirenz use raise the risk of suicide in people with HIV?
Studies look at community vs hospital-based HIV care and medication issues
Stribild is effective and well tolerated in older people with HIV
Switching from Atripla to Eviplera reduces central nervous system side-effects
New tenofovir formulation works equally well with less effect on kidneys and bones
